Biotech 2050 Podcast cover image

Transforming Gene Therapy: Exclusive Insights from Zandy Forbes, President & CEO of MeiraGTx

Biotech 2050 Podcast

CHAPTER

Exploring Capital Efficiency, Indication Selection, and Platform Precision in Gene Therapy

Exploring how the company is optimizing capital efficiency and diversifying their disease areas through strategic indication selection process and platform versatility for RNA production and delivering molecules.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner